Evidence map›Paper›PMID 41778182›Full record

ArticleEcancermedicalscience2025

Implementing cancer prevention strategies in India: progress, persistent challenges and future directions.

Jitendra Kumar Meena, Kavita Yadav, Ravi Mehrotra

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jitendra Kumar MeenaNational Cancer Institute (NCI), Jhajjar, Haryana 124105, India.
Kavita YadavGeorge Institute for Global Health, New Delhi 110025, India.
Ravi MehrotraEmory University, 1518 Clifton Rd, Atlanta, GA 30322, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a major and growing global health crisis, placing an immense and escalating burden on the health systems of developing countries like India. Given the substantial resources demanded by curative management, a strategic investment in comprehensive cancer prevention and control becomes not merely prudent but imperative. India faces a high incidence of tobacco and lifestyle-related cancers, which are largely preventable through robust public health approaches, including tobacco control, cessation support and Human Papilloma Virus vaccination. This narrative review critically assesses the status of cancer prevention and control services in India, highlighting key achievements, inherent challenges and potential threats to progress. While India's National Programme for Prevention and Control of Non-Communicable Diseases has initiated population-based cancer screening and expanded regional cancer centers, actual gains have been limited. This is due to implementation delays, suboptimal technical capacity and resource limitations in preventive services. Despite notable successes in areas like the cancer registry network, tobacco control legislation and the establishment of the National Cancer Grid, a consolidated and strategically implemented plan to effectively mitigate the projected increase in cancer burden remains a significant challenge.

Indexed as

cancer carecancer preventionIndiapreventive oncologypublic health

Identifiers

PMID41778182
PMCPMC12950889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.